Learn more about whether Amicus Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades ...

Valued at a market cap of $9.6 billion, Cambridge, Massachusetts-based Moderna, Inc. (MRNA) is a biotechnology company that ...

CAMBRIDGE, MA / ACCESS Newswire / April 7, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present research across multiple infectious disease areas, including COVID-19 ...

Learn more about whether Alvotech or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

CAMBRIDGE, MA - Moderna, Inc. (NASDAQ:MRNA), currently trading near its 52-week low of $29.25 and down over 70% in the past year, announced today that the Australian Therapeutic Goods ...

CAMBRIDGE, MA - Moderna Inc (BMV:MRNA). (NASDAQ:MRNA) is set to present a series of scientific studies at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global ...

CAMBRIDGE, MA / ACCESS Newswire / April 7, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present research across multiple infectious disease areas, including COVID-19, ...

CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Australian Therapeutic Goods Administration (TGA) has granted approval for mRESVIA® (mRNA ...

Decoy’s development of novel peptide-conjugate therapeutics arising from its proprietary IMP3ACT™ platform to benefit from Dr ...

E ven medical research isn’t immune to a federal overhaul. The life sciences have joined DEI efforts, climate laws and ...

Ten healthcare organizations were recognized on LinkedIn’s 2025 list of the best large employers for career growth. The ninth annual ranking evaluates companies with 5,000 or more global employees on ...